Journal of Clinical Endocrinology & Metabolism, Vol 81, 2848-2853, Copyright © 1996 by Endocrine Society

ARTICLES

Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study

MF Bellantoni, J Vittone, AT Campfield, KM Bass, SM Harman and MR Blackman
Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA.

To compare the effects of oral vs. transdermal estrogens on GH secretion and levels of circulating insulin-like growth factor I (IGF- I) and IGF-binding protein-3 (IGFBP-3) in younger vs. older postmenopausal women, we conducted a placebo-controlled, cross-over trial of 6 weeks of oral conjugated estrogen (1.25 mg daily) or transdermal estradiol (100 micrograms/day) administered in random order and separated by an 8-week, treatment-free interval. Sixteen healthy postmenopausal women, ages 49-75 yr, were studied on an NIH-funded General Clinical Research Center grant. Data were analyzed for the combined group as well as in the younger ( <or= 62 yr, n = 8) and older women ( > 62 yr, n = 8). Spontaneous GH secretion, as assessed by 12-h overnight blood sampling at 20-min intervals; GH responsiveness to i.v. bolus injection of GHRH; and levels of serum IGF-I and IGFBP-3, before and after GHRH stimulation, were measured at enrollment and after 6 weeks of each estrogen treatment. Before estrogen treatment, spontaneous nocturnal GH secretion and morning IGF-I levels tended to be lower, IGFBP-3 levels did not differ, and GHRH-stimulated GH levels were significantly reduced in older vs. younger postmenopausal women. Oral estrogens increased spontaneous GH secretion, decreased serum IGF- I levels, and did not alter IGFBP-3 levels, whereas transdermal estrogens did not alter nocturnal GH secretion or morning IGF-I levels and decreased IGFBP-3 levels only in the older women. GHRH-stimulated GH levels were similar before and after oral or transdermal estrogen treatment. In contrast, after, GHRH administration, IGF-I levels were decreased only with oral estrogens, whereas IGFBP-3 levels were decreased with both oral (younger women only) and transdermal (younger and older women) estrogens. We conclude that, in postmenopausal women, oral and transdermal estrogens exert differing effects on the GH/IGF-I axis, but neither form of estrogen completely reverses the known age- related reductions in spontaneous or GHRH-stimulated GH and IGF-I.

This article has been cited by other articles:

				M. Hansen, S. O. Koskinen, S. G. Petersen, S. Doessing, J. Frystyk, A. Flyvbjerg, E. Westh, S. P. Magnusson, M. Kjaer, and H. Langberg Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise J. Physiol., June 15, 2008; 586(12): 3005 - 3016. [Abstract] [Full Text] [PDF]

				N. Kalleinen, P. Polo-Kantola, K. Irjala, T. Porkka-Heiskanen, T. Vahlberg, A. Virkki, and O. Polo 24-Hour Serum Levels of Growth Hormone, Prolactin, and Cortisol in Pre- and Postmenopausal Women: The Effect of Combined Estrogen and Progestin Treatment J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1655 - 1661. [Abstract] [Full Text] [PDF]

				A. A van der Klaauw, N. R Biermasz, P. M J Zelissen, A. M Pereira, E. G W M Lentjes, J. W A Smit, S. W van Thiel, J. A Romijn, and F. Roelfsema Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism Eur. J. Endocrinol., December 1, 2007; 157(6): 709 - 716. [Abstract] [Full Text] [PDF]

				T. Munzer, C. J. Rosen, S.M. Harman, K. M. Pabst, C. St. Clair, J. D. Sorkin, and M. R. Blackman Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E1006 - E1013. [Abstract] [Full Text] [PDF]

				R. J. Cleveland, M. D. Gammon, S. N. Edmiston, S. L. Teitelbaum, J. A. Britton, M. B. Terry, S. M. Eng, A. I. Neugut, R. M. Santella, and K. Conway IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project Carcinogenesis, April 1, 2006; 27(4): 758 - 765. [Abstract] [Full Text] [PDF]

				D. Fintini, M. Alba, and R. Salvatori Influence of Estrogen Administration on the Growth Response to Growth Hormone (GH) in GH-Deficient Mice Experimental Biology and Medicine, November 1, 2005; 230(10): 715 - 720. [Abstract] [Full Text] [PDF]

				P. M. Mah, J. Webster, P. Jonsson, U. Feldt-Rasmussen, M. Koltowska-Haggstrom, and R. J. M. Ross Estrogen Replacement in Women of Fertile Years with Hypopituitarism J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5964 - 5969. [Abstract] [Full Text] [PDF]

				P. Y. Liu, K. A. Hoey, K. L. Mielke, J. D. Veldhuis, and S. Khosla A Randomized Placebo-Controlled Trial of Short-Term Graded Transdermal Estradiol in Healthy Gonadotropin-Releasing Hormone Agonist-Suppressed Pre- and Postmenopausal Women: Effects on Serum Markers of Bone Turnover, Insulin-Like Growth Factor-I, and Osteoclastogenic Mediators J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1953 - 1960. [Abstract] [Full Text] [PDF]

				X.-D. Qu, I. T. Gaw Gonzalo, M. Y. Al Sayed, P. Cohan, P. D. Christenson, R. S. Swerdloff, D. F. Kelly, and C. Wang Influence of Body Mass Index and Gender on Growth Hormone (GH) Responses to GH-Releasing Hormone Plus Arginine and Insulin Tolerance Tests J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1563 - 1569. [Abstract] [Full Text] [PDF]

				R. Coutant, F. B. de Casson, S. Rouleau, O. Douay, E. Mathieu, F. Gatelais, N. Bouhours-Nouet, C. Voinot, M. Audran, and J. M. Limal Divergent Effect of Endogenous and Exogenous Sex Steroids on the Insulin-Like Growth Factor I Response to Growth Hormone in Short Normal Adolescents J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6185 - 6192. [Abstract] [Full Text] [PDF]

				K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF]

				S. Schurgin, S. Dolan, A. Perlstein, M. P. Sullivan, N. Aliabadi, and S. Grinspoon Effects of Testosterone Administration on Growth Hormone Pulse Dynamics in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3290 - 3297. [Abstract] [Full Text] [PDF]

				C. A. Lissett and S. M. Shalet The Impact of Dose and Route of Estrogen Administration on the Somatotropic Axis in Normal Women J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4668 - 4672. [Abstract] [Full Text] [PDF]

				S. K. Grinspoon, A. J. Friedman, K. K. Miller, J. Lippman, W. H. Olson, and M. P. Warren Effects of a Triphasic Combination Oral Contraceptive Containing Norgestimate/Ethinyl Estradiol on Biochemical Markers of Bone Metabolism in Young Women with Osteopenia Secondary to Hypothalamic Amenorrhea J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3651 - 3656. [Abstract] [Full Text] [PDF]

				S. Grinspoon, K. Miller, D. Herzog, D. Clemmons, and A. Klibanski Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I and Estrogen Administration on IGF-I, IGF Binding Protein (IGFBP)-2, and IGFBP-3 in Anorexia Nervosa: A Randomized-Controlled Study J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1142 - 1149. [Abstract] [Full Text] [PDF]

				N. D. Borofsky, J. H. Vogelman, R. A. Krajcik, and N. Orentreich Utility of Insulin-like Growth Factor-1 as a Biomarker in Epidemiologic Studies Clin. Chem., December 1, 2002; 48(12): 2248 - 2251. [Full Text] [PDF]

				M. J. Woller, G. Everson-Binotto, E. Nichols, A. Acheson, K. L. Keen, C. Y. Bowers, and E. Terasawa Aging-Related Changes in Release of Growth Hormone and Luteinizing Hormone in Female Rhesus Monkeys J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5160 - 5167. [Abstract] [Full Text] [PDF]

				C. Christmas, K. G. O'Connor, S. M. Harman, J. D. Tobin, T. Munzer, M. F. Bellantoni, C. St. Clair, K. M. Pabst, J. D. Sorkin, and M. R. Blackman Growth Hormone and Sex Steroid Effects on Bone Metabolism and Bone Mineral Density in Healthy Aged Women and Men J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M12 - 18. [Abstract] [Full Text] [PDF]

				H. J. Lieman, T. E. Adel, C. Forst, S. Von Hagen, and N. Santoro Effects of Aging and Estradiol Supplementation on GH Axis Dynamics in Women J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3918 - 3923. [Abstract] [Full Text] [PDF]

				A. M. Oleksik, T. Duong, N. Pliester, G. Asma, C. Popp-Snijders, and P. Lips Effects of the Selective Estrogen Receptor Modulator, Raloxifene, on the Somatotropic Axis and Insulin-Glucose Homeostasis J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2763 - 2768. [Abstract] [Full Text] [PDF]

				C. H. Gravholt, J. Frystyk, A. Flyvbjerg, H. Orskov, and J. S. Christiansen Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E308 - E314. [Abstract] [Full Text] [PDF]

				G. Y. W. Kam, K.-C. Leung, R. C. Baxter, and Ken. K. Y. Ho Estrogens Exert Route- and Dose-Dependent Effects on Insulin-Like Growth Factor (IGF)-Binding Protein-3 and the Acid-Labile Subunit of the IGF Ternary Complex J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1918 - 1922. [Abstract] [Full Text]

				J. P. T. Span, G. F. F. M. Pieters, C. G. J. Sweep, A. R. M. M. Hermus, and A. G. H. Smals Gender Difference in Insulin-Like Growth Factor I Response to Growth Hormone (GH) Treatment in GH-Deficient Adults: Role of Sex Hormone Replacement J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1121 - 1125. [Abstract] [Full Text]

				Y. J. H. Janssen, F. Helmerhorst, M. Frölich, and F. Roelfsema A Switch from Oral (2 mg/Day) to Transdermal (50 {micro}g/Day) 17{beta}-Estradiol Therapy Increases Serum Insulin-Like Growth Factor-I Levels in Recombinant Human Growth Hormone (GH)-Substituted Women with GH Deficiency J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 464 - 467. [Abstract] [Full Text]

				P. C. Hindmarsh, E. Dennison, S. M. Pincus, C. Cooper, C. H. D. Fall, D. R. Matthews, P. J. Pringle, and C. G. D. Brook A Sexually Dimorphic Pattern of Growth Hormone Secretion in the Elderly J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2679 - 2685. [Abstract] [Full Text]

				L. G. Raisz and K. M. Prestwood Estrogen and the Risk of Fracture -- New Data, New Questions N. Engl. J. Med., September 10, 1998; 339(11): 767 - 768. [Full Text]

				B. Ettinger, A. Pressman, P. Sklarin, D. C. Bauer, J. A. Cauley, and S. R. Cummings Associations between Low Levels of Serum Estradiol, Bone Density, and Fractures among Elderly Women: The Study of Osteoporotic Fractures J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2239 - 2243. [Abstract] [Full Text]

				M. E. Wilson Regulation of the Growth Hormone-Insulin-Like Growth Factor I Axis in Developing and Adult Monkeys Is Affected by Estradiol Replacement and Supplementation with Insulin-Like Growth Factor I J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2018 - 2028. [Abstract] [Full Text]

				M. Paassilta, K. Kervinen, M. Linnaluoto, and Y. A. Kesaniemi Alcohol Withdrawal–Induced Change in Lipoprotein(a) : Association With the Growth Hormone/Insulin-like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 650 - 654. [Abstract] [Full Text] [PDF]

				R. R. Kraemer, L. G. Johnson, R. Haltom, G. R. Kraemer, H. Gaines, M. Drapcho, T. Gimple, and V. D. Castracane Effects of hormone replacement on growth hormone and prolactin exercise responses in postmenopausal women J Appl Physiol, February 1, 1998; 84(2): 703 - 708. [Abstract] [Full Text] [PDF]

				K. Wiedemann, C. J. Lauer, M. Hirschmann, K. Knaudt, and F. Holsboer Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E139 - E145. [Abstract] [Full Text] [PDF]

				D. A. Fryburg, A. Weltman, L. A. Jahn, J. Y. Weltman, E. Samojlik, R. L. Hintz, and J. D. Veldhuis Short-Term Modulation of the Androgen Milieu Alters Pulsatile, But Not Exercise- or Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Healthy Men: Impact of Gonadal Steroid and GH Secretory Changes on Metabolic Outcomes J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3710 - 3719. [Abstract] [Full Text] [PDF]